Innovate UK and a group of private equity investors are putting more than £16 million into projects aimed at developing personalised medicines.
The funding will be delivered through the Precision Medicine Investment Accelerator competition, with Innovate UK contributing almost £7m and private equity investors providing around £10m, UK Research and Innovation said in a statement on 7 August. The competition will support projects that offer “disruptive change” to systems for diagnosing, monitoring and treating disease.
Thirteen projects are being supported by the accelerator, with work starting during the summer and continuing for two years.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.